Concepedia

Helmut Haning

HH

Statistics

Publications

13

Citations

670

H-Index

13

Active since

1992

Affiliations

Bayer (Germany)(Current)

Max-Planck-Institut für Kohlenforschung

Max Planck Society

Helmut Haning is an author at Bayer (Germany) specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

1992–2015

13

Publications

13

The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil

I Sáenz de Tejada, Javier Angulo, Pedro Cuevas et al. · International Journal of Impotence Research · 2001 · 231 citations

, , +13

Imidazo[5,1-f][1,2,4]triazin-4(3H)-ones, a new class of potent PDE 5 inhibitors

Helmut Haning, Ulrich Niewöhner, Thomas Schenke et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 75 citations · Full text

, , +7

Freezing the Bioactive Conformation to Boost Potency: The Identification of BAY 85‐8501, a Selective and Potent Inhibitor of Human Neutrophil Elastase for Pulmonary Diseases

Franz von Nussbaum, Volkhart M.‐J. Li, Swen Allerheiligen et al. · ChemMedChem · 2015 · 67 citations · Full text

, , +17

THE ORAL EFFICACY OF VARDENAFIL HYDROCHLORIDE FOR INDUCING PENILE ERECTION IN A CONSCIOUS RABBIT MODEL

Erwin Bischoff, U. NIEWOEHNER, Helmut Haning et al. · The Journal of Urology · 2001 · 49 citations

, , +6

Ligand effects in selective carbonyl addition reactions of organomanganese and cerium reagents

Manfred T. Reetz, Helmut Haning, Stephan Stanchev · Tetrahedron Letters · 1992 · 44 citations

, , +11

1–5 of 13